# Autophagy crosstalk with the immune microenvironment in chronic myeloid leukemia and serves as a biomarker for diagnosis and progression

## TL;DR

This study explores how autophagy in chronic myeloid leukemia affects the immune system and could serve as a biomarker for diagnosis and disease progression.

## Contribution

The study identifies autophagy-related genes as potential diagnostic biomarkers and explores their role in immune interactions in CML.

## Key findings

- CML samples show significantly lower autophagy scores and downregulated autophagy-related genes compared to normal samples.
- High autophagy scores correlate with increased regulatory T-cell infiltration and cytokine signaling, while low scores are linked to γδT cell infiltration and treatment resistance.
- Three autophagy-related genes (FOXO1, TUSC1, ATG4A) were identified as effective diagnostic markers for CML and other hematological malignancies.

## Abstract

Previous studies have shown that autophagy is closely related to the occurrence, development, and treatment resistance of chronic myeloid leukemia (CML) and has dual roles in promoting cell survival and inducing cell death.

We analyzed autophagy levels in CML samples via transcriptome data and evaluated the relationships between autophagy and the immune microenvironment, treatment response, and disease progression. A consensus clustering algorithm was used to identify autophagy-related molecular subtypes. The value of autophagy-related genes (ARGs) in diagnosis and treatment evaluation was analyzed and verified by a variety of machine learning algorithms.

Compared with normal samples, CML samples had significantly lower autophagy scores and more downregulated ARGs. The autophagy score was positively correlated with the activity of immune and signal transduction-related pathways and negatively correlated with proliferation-related pathways. Patients with high autophagy scores had a greater proportion of regulatory T-cell infiltration and greater cytokine–cytokine receptor interaction signaling pathway activity, while patients with low autophagy scores had greater γδT cell infiltration and PD-1 expression. Low autophagy scores are also associated with malignant progression and nonresponse to treatment. The immune landscape and chemotherapy sensitivity significantly differed between the two autophagy-related molecular subtypes. Three diagnostic ARGs (FOXO1, TUSC1, and ATG4A) were identified by support vector machine recursive feature elimination, least absolute shrinkage selection operator, and random forest algorithms, and the combined diagnostic efficiency of the three was further improved. The diagnostic value of the three ARGs was verified by an additional validation cohort and our clinical real-world clinical cohort, and they can also be used for the differential diagnosis of CML from other hematological malignancies.

Our study revealed that CML samples exhibit decreased autophagy, and autophagy may induce Tregs to undergo immunosuppression through cytokines. Autophagy-related molecular subtypes are helpful for guiding the clinical treatment of CML. The identification of ARGs by a variety of machine learning algorithms has potential clinical application value.